Add a description about your page or projects. Should be around 135 to 160 characters.
Total raised: $17.23M
Investors 1
| Date | Name | Website |
| 13.05.2024 | Bioqube Ve... | bioqubeven... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 09.05.2024 | Seed | $17.23M | - |
Mentions in press and media 4
| Date | Title | Description |
| 07.09.2024 | Commit Biologics launches with €16m seed financing to pioneer complement system activation to treat cancer and autoimmune disease | Aarhus, Denmark – 9 May 2024 – Commit Biologics (“Commit”), a pioneer in the activation of the complement system to treat cancer and autoimmune disease, today exits from stealth with €16m in seed funding from Bioqube Ventures and Novo Holdi... |
| 12.08.2024 | The endgame: 10 European startups aiming to defeat cancer | Cancer remains one of the most pressing global health challenges, claiming millions of lives each year and impacting countless more. Despite significant advancements in research and treatment, the fight against cancer demands continuous inn... |
| 09.05.2024 | Commit Biologics Raises €16M in Seed Financing | Commit Biologics, an Aarhusm, a Denmark-based company which specializes in activating the complement system to treat cancer and autoimmune disease, raised €16M in Seed funding. Backers included Bioqube Ventures and Novo Holdings. The compan... |
| - | Commit Biologics | “Add a description about your page or projects. Should be around 135 to 160 characters.” |